Last reviewed · How we verify
Synergy for Pseudomonas Aeruginosa Osteomyelitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Gentamicin · Merck & Co.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Synergy for Pseudomonas Aeruginosa Osteomyelitis patent landscape — cliff calendar, originator estates, attackable patents
- Synergy for Pseudomonas Aeruginosa Osteomyelitis treatment landscape brief
- Synergy for Pseudomonas Aeruginosa Osteomyelitis treatment updates RSS
Frequently asked questions about Synergy for Pseudomonas Aeruginosa Osteomyelitis
What drugs treat Synergy for Pseudomonas Aeruginosa Osteomyelitis?
Tracked treatments include Ramycin, Garamycin, Gentamicin.
What is the treatment for Synergy for Pseudomonas Aeruginosa Osteomyelitis?
Standard treatment for Synergy for Pseudomonas Aeruginosa Osteomyelitis includes Ramycin, Garamycin, Gentamicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Synergy for Pseudomonas Aeruginosa Osteomyelitis patent cliff · Synergy for Pseudomonas Aeruginosa Osteomyelitis CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Gentamicin · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing